1. Home
  2. SONO vs INBX Comparison

SONO vs INBX Comparison

Compare SONO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

N/A

Current Price

$17.79

Market Cap

1.8B

ML Signal

N/A

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

N/A

Current Price

$98.94

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SONO
INBX
Founded
2002
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
SONO
INBX
Price
$17.79
$98.94
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$18.63
★ $266.67
AVG Volume (30 Days)
★ 1.6M
282.4K
Earning Date
11-04-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.77
N/A
Revenue
★ $1,443,276,000.00
$1,300,000.00
Revenue This Year
$6.89
N/A
Revenue Next Year
$5.65
N/A
P/E Ratio
$23.06
★ N/A
Revenue Growth
N/A
★ 550.00
52 Week Low
$12.44
$28.16
52 Week High
$19.82
$155.29

Technical Indicators

Market Signals
Indicator
SONO
INBX
Relative Strength Index (RSI) 64.88 43.08
Support Level $14.11 $96.60
Resistance Level $18.66 $106.40
Average True Range (ATR) 0.57 5.75
MACD 0.20 -1.44
Stochastic Oscillator 88.73 11.13

Price Performance

Historical Comparison
SONO
INBX

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: